← All Sponsors
SPONSOR

Lantern Pharma Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Relapsed or Refractory LymphomasAdvanced Solid Tumor
NCT06132503 Phase 1
Recruiting

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Relapsed or Refractory Lymphomas
United States View Trial →